Immune Design partners with 2 nonprofits on cancer immunotherapy

06/13/2013 | Xconomy

Immune Design will work with the Ludwig Institute for Cancer Research and the Cancer Research Institute to test a vaccine and adjuvant in ongoing clinical trials for other cancer immunotherapies. The Column Group, Versant Ventures and Alta Partners have invested $50 million in Immune Design, and the CEO expects to launch a new funding round soon.

View Full Article in:

Xconomy

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA